Loracarbef Production Cost Reports

The report provides a detailed analysis essential for establishing a Loracarbef production plant. It encompasses all critical aspects necessary for Loracarbef production, including the cost of Loracarbef production, Loracarbef plant cost, Loracarbef production costs, and the overall Loracarbef production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Loracarbef production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Loracarbef is an antibiotic that belongs to the class of beta-lactam drugs, used primarily to treat bacterial infections. It is commonly prescribed for respiratory infections, such as bronchitis, pneumonia, and sinusitis, caused by susceptible bacteria. It works by inhibiting the growth of bacteria, which makes it effective in fighting both Gram-positive and Gram-negative infections. It is also used to treat urinary tract infections (UTIs) and skin infections. Loracarbef is administered orally and is well-absorbed in the body, which makes it a convenient option for outpatient treatment. It also finds its application in the treatment of some ear infections, which helps to reduce the symptoms of bacterial ear inflammation.

The primary factor that drives the market for Loracarbef is its demand as an oral antibiotic in the treatment of a wide range of infections caused by both gram-positive and gram-negative bacteria. Its application as a medication in treating upper and lower respiratory tract infections, along with urinary tract infections, also increases its demand in the medical and healthcare sectors. Its usage as an antibiotic drug in the treatment of sinusitis, bronchitis, skin infections, and otitis media (middle ear infections) further boosts its demand in the pharmaceutical industry. Its demand as a broad-spectrum antibiotic in treating bacterial infections, particularly in outpatient settings, largely promotes its market expansion.

The growing global prevalence of bacterial infections, along with the rise of antibiotic-resistant strains, also fuels the demand for Loracarbef. Industrial Loracarbef procurement is influenced by key factors such as the cost and availability of raw materials, regulatory approvals, and adherence to environmental standards. Furthermore, advancements in production processes, supplier reliability, sustainability initiatives, and efficient distribution networks play an important role in shaping the global procurement decisions for Loracarbef.

Raw Material for Loracarbef Production

According to the Loracarbef production plant project report, the major raw materials for Loracarbef production include Cis-racemic Azetidinone Salt and Methyl Phenoxyacetate.

Production Process of Loracarbef

The extensive Loracarbef production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of Loracarbef begins with the reaction of a cis-racemic azetidinone salt with methyl phenoxyacetate, which selectively provides the (2R,3S)-enantiomer of the amide product. This reaction is carried out at a pH of 6.0 and a temperature of 28 degree Celsius. The product precipitates out of the aqueous medium, which helps drive the reaction forward while preventing enzyme-catalysed hydrolysis of the product. The complete process results in the formation of Loracarbef as the final product.

Loracarbef is a synthetic carbacephem antibiotic belonging to the second-generation cephalosporin class, and it is a carba analogue of cefaclor with enhanced chemical stability. It exists as a white to off-white crystalline powder and is practically insoluble in water but exhibits solubility in dimethyl sulfoxide. The molecular formula of the anhydrous compound is C16H16ClN3O4, and its molecular mass is 349.77 g/mol. The compound decomposes at its melting point, which is between 205 and 215 degree Celsius. The compound exhibits remarkable solution stability compared to other cephalosporins and demonstrates a U-shaped pH-stability profile characteristic of zwitterionic cephalosporins, with maximum stability at its isoelectric point. It is marketed under the trade name Lorabid and is used for the treatment of bacterial infections, including respiratory tract infections, urinary tract infections, and skin infections. The compound should be stored in dry, dark conditions at low temperatures to maintain stability. Extended exposure or inappropriate use of this antibiotic may lead to serious health problems such as allergic reactions, gastrointestinal disturbances, and the development of antibiotic-resistant bacterial strains.